{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:33:01Z","timestamp":1778286781417,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tokushima University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ejps.2015.09.015","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:44:23Z","timestamp":1443573863000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model"],"prefix":"10.1016","volume":"81","author":[{"given":"Noha Essam","family":"Eldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr S.","family":"Abu Lila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Kawazoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan M.","family":"Elnahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.09.015_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2009.02.023","article-title":"Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model","volume":"137","author":"Abu Lila","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.09.015_bb0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2008.10.018","article-title":"Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model","volume":"134","author":"Abu-Lila","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.09.015_bb0015","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s11096-014-0032-9","article-title":"Acute and fatal thrombocytopenic thrombotic purpura after a single dose of pemetrexed","volume":"36","author":"Alabiso","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.ejps.2015.09.015_bb0020","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.2042-7158.2010.01090.x","article-title":"Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent","volume":"62","author":"Ali","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2015.09.015_bb0025","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/1078-0432.CCR-04-2517","article-title":"Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates","volume":"11","author":"Allen","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2015.09.015_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.12.038","article-title":"Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature","volume":"200","author":"Araki","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.09.015_bb0035","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2217\/nnm.12.87","article-title":"Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system","volume":"7","author":"Bamrungsap","year":"2012","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.ejps.2015.09.015_bb0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1535-7163.MCT-06-0343","article-title":"Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications","volume":"6","author":"Chattopadhyay","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2015.09.015_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2146\/ajhp110281","article-title":"Malignant pleural mesothelioma","volume":"69","author":"Chen","year":"2012","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejps.2015.09.015_bb0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1470-2045(00)00325-9","article-title":"Pemetrexed disodium, a novel antifolate with multiple targets","volume":"2","author":"Curtin","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejps.2015.09.015_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2007.11.030","article-title":"The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats","volume":"353","author":"Dadashzadeh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.09.015_bb0060","doi-asserted-by":"crossref","DOI":"10.4081\/cp.2011.e106","article-title":"Pemetrexed induced pneumonitis","volume":"1","author":"Dhakal","year":"2011","journal-title":"Clin. Pract."},{"key":"10.1016\/j.ejps.2015.09.015_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1248\/bpb.b14-00769","article-title":"Liposomal pemetrexed: formulation, characterization and in vitro cytotoxicity studies for effective management of malignant pleural mesothelioma","volume":"38","author":"Essam Eldin","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2015.09.015_bb0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2015.09.015_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01059781","article-title":"Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency","volume":"21","author":"Harashima","year":"1993","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2015.09.015_bb0080","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ijc.25716","article-title":"Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma","volume":"129","author":"Iwahori","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2015.09.015_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2015.09.015_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2008.01.017","article-title":"Study of the antitumor potential of Bidens pilosa (Asteraceae) used in Brazilian folk medicine","volume":"117","author":"Kviecinski","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2015.09.015_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.09.015_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-4157(92)90039-D","article-title":"Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications","volume":"1113","author":"Litzinger","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2015.09.015_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0005-2736(00)00203-0","article-title":"Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo","volume":"1466","author":"Lopes de Menezes","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2015.09.015_bb0110","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/CAD.0b013e328356dc11","article-title":"Superior antimetastatic effect of pemetrexed-loaded gelatinase-responsive nanoparticles in a mouse metastasis model","volume":"23","author":"Lu","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejps.2015.09.015_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.ejps.2015.09.015_bb0120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/annonc\/mdh279","article-title":"Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors","volume":"15","author":"Misset","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejps.2015.09.015_bb0125","doi-asserted-by":"crossref","first-page":"15841","DOI":"10.1039\/C4DT02144D","article-title":"Multifunctional mesoporous hollow silica nanocapsules for targeted co-delivery of cisplatin-pemetrexed and MR imaging","volume":"43","author":"Mohapatra","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejps.2015.09.015_bb0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ejps.2015.09.015_bb0135","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/JTO.0b013e31825f22ee","article-title":"A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma","volume":"7","author":"Nowak","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejps.2015.09.015_bb0140","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.081626898","article-title":"Role of tumor\u2013host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors","volume":"98","author":"Pluen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2015.09.015_bb0145","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/jps.21270","article-title":"Nanovehicular intracellular delivery systems","volume":"97","author":"Prokop","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.09.015_bb0150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10637-010-9414-6","article-title":"Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer","volume":"29","author":"Richards","year":"2011","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ejps.2015.09.015_bb0155","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1158\/0008-5472.CAN-10-1873","article-title":"Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas","volume":"70","author":"Rothbart","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2015.09.015_bb0160","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02531316","article-title":"Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots","volume":"5","author":"Rouser","year":"1970","journal-title":"Lipids"},{"key":"10.1016\/j.ejps.2015.09.015_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/CCO.0b013e328324bc30","article-title":"Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?","volume":"21","author":"Stahel","year":"2009","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ejps.2015.09.015_bb0170","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2217\/nnm.14.97","article-title":"Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment","volume":"9","author":"Su","year":"2014","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.ejps.2015.09.015_bb0175","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/bjc.2011.129","article-title":"Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer","volume":"104","author":"Takezawa","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2015.09.015_bb0180","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1349-7006.2010.01690.x","article-title":"ABCC11\/MRP8 confers pemetrexed resistance in lung cancer","volume":"101","author":"Uemura","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejps.2015.09.015_bb0185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2011.04.008","article-title":"PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy","volume":"412","author":"Yoshizawa","year":"2011","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715300233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715300233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T02:20:29Z","timestamp":1537323629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715300233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":37,"alternative-id":["S0928098715300233"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.09.015","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}